TITLE

MEMANTINE

PUB. DATE
January 2008
SOURCE
Complete Guide to Prescription & Nonprescription Drugs 2012;2008, p526
SOURCE TYPE
Encyclopedia
DOC. TYPE
Article
ABSTRACT
The article presents information on memantine, a drug used for the treatment of moderate to severe symptoms of Alzheimer's disease. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible interaction of the drug with other drugs is also mentioned.
ACCESSION #
31715142

 

Related Articles

  • MEMANTINE.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p534 

    The article presents information on memantine, a N-methyl-D-aspartate (NMDA) receptor antagonist, including its dosage, usage, adverse reactions or side effects, precautions when administering, and possible interaction with other drugs and substances.

  • MEMANTINE.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2007, p528 

    The article presents information on memantine, a drug used for the treatment of moderate to severe symptoms of Alzheimer’s disease. The dosage and usage information is provided. The possible adverse reactions or side effects of the drug, warnings, and precautions are discussed. Possible...

  • MEMANTINE. Griffith, W. Winter // Complete Guide to Prescription & Nonprescription Drugs 2012;2009, p530 

    The article presents information on memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist drug, including dosage, usage, adverse reactions, side effects, precautions, and possible interaction with other drugs.

  • MEMANTINE. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2011, p530 

    The article presents information on memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • MEMANTINE. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2010, p530 

    The article presents information on memantine, a N-methyl-D-aspartate receptor antagonist, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • Open label, multicenter, 28-week extension study of the safety and tolerability of memantine in patients with mild to moderate Alzheimer’s disease. Ott, Brian R.; Blake, Lesley M.; Kagan, Ethel; Resnick, Malca // Journal of Neurology;Mar2007, Vol. 254 Issue 3, p351 

    Memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist, has been shown to be safe and to have beneficial effects on cognition, function, behavior, and global patient status in patients with Alzheimer’s disease (AD) in studies lasting 3–6 months. It is approved in the U.S....

  • ACARBOSE.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p6 

    The article presents information on acarbose, an antihyperglycemic and antidiabetic drug, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • NARCOTIC ANALGESICS.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p582 

    The article presents information on narcotic analgesics, including their dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • Treating Alzheimer's? Don't forget about cholinesterase inhibitor drug interactions. Adis International Limited // Drugs & Therapy Perspectives;Jul2004, Vol. 20 Issue 7, p20 

    Presents information on various drug effects of cholinesterase inhibitor during the treatment of Alzheimer's disease. Importance of the discontinuation of cholinesterase inhibitors prior to surgery to drug interactions resulting from coadministration with neuromuscular blocking agents; Impact...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics